Monotherapy with α-Blocker or Phosphodiesterase 5 Inhibitor for Lower Urinary Tract Symptoms?

被引：2
|
作者：
Chapple, Christopher R. [1 ]
机构：
[1] Sheffield Teaching Hosp NHS Trust, Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England
来源：
EUROPEAN UROLOGY | 2012年 / 61卷 / 05期
关键词：
BENIGN PROSTATIC HYPERPLASIA; ERECTILE DYSFUNCTION; TADALAFIL; SECONDARY; COMBINATION; MANAGEMENT; SILDENAFIL; ALFUZOSIN; SUPERIOR; EFFICACY;
D O I：
10.1016/j.eururo.2012.02.040
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：926 / 927
页数：2
相关论文
共 50 条
  • [31] Daily use of phosphodiesterase 5 inhibitors for erectile dysfunction and lower urinary tract symptoms
    Pimentel, H.
    Wald, M.
    Niederberger, C.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2008, 20 (02) : 145 - 149
  • [32] Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta-analysis
    Wang, Yilin
    Bao, Yiping
    Liu, Jie
    Duan, Lijun
    Cui, Yuanshan
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2018, 10 (01) : 84 - 92
  • [33] Study of phosphodiesterase 5 inhibitors and a-adrenoceptor antagonists used alone or in combination for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia
    Sun, Yi
    Peng, Bo
    Lei, Guo-Lin
    Wei, Qiang
    Yang, Lu
    MINERVA UROLOGICA E NEFROLOGICA, 2020, 72 (01) : 13 - 21
  • [34] A META-ANALYSIS OF LONG-VERSUS SHORT-ACTING PHOSPHODIESTERASE 5 INHIBITORS: COMPARING COMBINATION USE WITH A-BLOCKERS AND A-BLOCKER MONOTHERAPY FOR LOWER URINARY TRACT SYMPTOMS
    Choi, H.
    Bae, J. H.
    Yeo, J. K.
    Tae, S. J.
    Lee, J. G.
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S207 - S208
  • [35] Alpha-blockers with or without phosphodiesterase type 5 inhibitor for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review and meta-analysis
    Zhang, Jianzhong
    Li, Xiao
    Yang, Bin
    Wu, Cheng
    Fan, Yanghua
    Li, Hongjun
    WORLD JOURNAL OF UROLOGY, 2019, 37 (01) : 143 - 153
  • [36] Phosphodiesterase-5 inhibitors in the treatment of lower urinary tract symptoms and benign prostatic hyperplasia
    Giannitsas, Konstantinos
    Mitropoulos, Dionisios
    Konstantinopoulos, Angelis
    Athanasopoulos, Anastasios
    Perimenis, Petros
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (10) : 1687 - 1693
  • [37] Lower Urinary Tract Symptoms
    Gammack, Julie K.
    CLINICS IN GERIATRIC MEDICINE, 2010, 26 (02) : 249 - +
  • [38] Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial
    Sebastianelli, Arcangelo
    Spatafora, Pietro
    Frizzi, Jacopo
    Saleh, Omar
    Sessa, Maurizio
    De Nunzio, Cosimo
    Tubaro, Andrea
    Vignozzi, Linda
    Maggi, Mario
    Serni, Sergio
    McVary, Kevin T.
    Kaplan, Steven A.
    Gravas, Stavros
    Chapple, Christopher
    Gacci, Mauro
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)
  • [39] Phosphodiesterase-5 Expression and Function in the Lower Urinary Tract: A Critical Review
    Lin, Ching-Shwun
    Albersen, Maarten
    Xin, Zhongcheng
    Namiki, Mikio
    Muller, Dieter
    Lue, Tom F.
    UROLOGY, 2013, 81 (03) : 480 - 487
  • [40] The Efficacy of PDE5 Inhibitors Alone or in Combination with Alpha-Blockers for the Treatment of Erectile Dysfunction and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
    Yan, Huilei
    Zong, Huantao
    Cui, Yuanshan
    Li, Nan
    Zhang, Yong
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 (06) : 1539 - 1545
12345